Dr Daniel Ajzensztejn

Dr Daniel Ajzensztejn is a Consultant Clinical Oncologist specialising in the treatment of lung cancers, mesothelioma and skin cancers. He focuses on cutting edge personalised treatments including stereotactic ablative radiotherapy (SABR/SBRT) and immunotherapy. Dr Ajzensztejn undertook a DPhil (PhD) at Oxford University where his research focused on ways to use the body's own immune system to fight cancer. He continues to be involved in clinical research and is the principle investigator for a number of clinical trials. He is an NHS consultant at Oxford University Hospitals, and also undertakes an NHS clinic at Milton Keynes University Hospital. He sees private patients at GenesisCare Oxford and Milton Keynes. Qualifications: FRCR Clinical Oncology · Royal College of Radiologists DPhil (PhD) · Tumour Immunology · Oxford University MSc Oncology · Institute of Cancer Research MRCP · Royal College of Physicians of London MBBS Medicine · University College London BSc Pharmacology · University College London